A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021 (vol 395, pg 867, 2022)

被引：0
|
作者：
Kayki-Mutlu, Gizem [1 ]
Aksoyalp, Zinnet Sevval [2 ]
Wojnowski, Leszek [3 ]
Michel, Martin C. [3 ]
机构：
[1] Ankara Univ, Fac Pharm, Dept Pharmacol, Ankara, Turkey
[2] Izmir Katip Celebi Univ, Fac Pharm, Dept Pharmacol, Izmir, Turkey
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, Langenbeckstr. 1, D-55118 Mainz, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2023年 / 396卷 / 02期
关键词：
D O I：
10.1007/s00210-022-02320-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：383 / 383
页数：1
相关论文
共 50 条
  • [21] RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
    Cherny, Nathan I.
    Dafni, Urani
    Bogaerts, Jan
    Latino, Nicola J.
    Pentheroudakis, George
    Douillard, Jean-Yves
    Tabernero, Josep
    Zielinski, Christoph
    Piccart, Martine J.
    de Vries, Elisabeth G. E.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (10)
  • [22] A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration
    He, Qian
    Li, Qiu
    Lv, Fanzhen
    Kaitin, Kenneth I.
    Shao, Liming
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (04) : 676 - 684
  • [23] Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
    Sang, Angela
    Zhuo, Selena
    Bochanis, Adara
    Manautou, Jose E.
    Bahal, Raman
    Zhong, Xiao-bo
    Rasmussen, Theodore P.
    [J]. BIODRUGS, 2024, 38 (04) : 511 - 526
  • [24] A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration
    Qian He
    Qiu Li
    Fanzhen Lv
    Kenneth I. Kaitin
    Liming Shao
    [J]. Therapeutic Innovation & Regulatory Science, 2021, 55 : 676 - 684
  • [25] Update on Novel Drugs for Primary Care Practice: Drugs Approved by the US Food and Drug Administration in 2015
    Smetana, Gerald W.
    [J]. ANNALS OF INTERNAL MEDICINE, 2016, 164 (09) : W48 - W54
  • [26] Role of US military research programs in the development of US Food and Drug Administration - Approved antimalarial drugs
    Kitchen, LW
    Vaughn, DW
    Skillman, DR
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) : 67 - 71
  • [27] The New Food and Drug Administration Approved Drugs in 2014: a 2015 Report Analysis
    Santos, Wilson C.
    da Silva, Fernando C.
    Pinto, Angelo C.
    Ferreira, Vitor F.
    [J]. REVISTA VIRTUAL DE QUIMICA, 2015, 7 (04) : 1535 - 1551
  • [28] Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021
    Monge, Andrea N.
    Sigelman, Daniel W.
    Temple, Robert J.
    Chahal, Harinder Singh
    [J]. JAMA NETWORK OPEN, 2022, 5 (11) : e2239336
  • [29] New antimicrobial agents approved by the US Food and Drug Administration in 2001 and new indications for previously approved agents
    不详
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) : 1160 - 1160
  • [30] New antimicrobial agents approved by the US Food and Drug Administration in 1998 and new indications for previously approved agents
    不详
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 993 - 994
12345